Table 2—

Characteristics of the population with type 2 diabetes, according to retinopathy status: the AusDiab study

RetinopathyNo retinopathyP
n 96 607  
Age (years) 65 ± 11 62 ± 12 0.016 
Male (%) 45 51 0.241 
Fasting plasma glucose (mmol/l) 10.2 ± 4.5 7.9 ± 2.4 <0.001 
HbA1c (%) 7.4 (5.9–8.5) 6.0 (5.6–6.8) <0.001 
Known diabetes (%) 76 43 <0.001 
Duration of diabetes (years)* 7 (0–15) 0 (0–4) <0.001 
On insulin or tablets (%) 82 65 0.004 
BMI (kg/m230.3 ± 5.6 30.2 ± 6.1 0.984 
Cholesterol (mmol/l) 5.5 ± 1.0 5.7 ± 1.0 0.115 
Triglycerides (mmol/l) 1.8 (1.3–2.6) 1.9 (1.3–2.7) 0.572 
Current smoker (%) 11 0.574 
Hypertension (%) 72 66 0.288 
SBP (mmHg) 148 ± 24 140 ± 18 <0.001 
DBP (mmHg) 78 ± 10 79 ± 10 0.415 
C-peptide (ng/ml) 3.2 ± 1.7 3.8 ± 1.7 0.001 
Urinary albumin:creatinine ratio (mg/mmol) 1.72 (0.8–6.3) 0.97 (0.6–2.3) <0.001 
RetinopathyNo retinopathyP
n 96 607  
Age (years) 65 ± 11 62 ± 12 0.016 
Male (%) 45 51 0.241 
Fasting plasma glucose (mmol/l) 10.2 ± 4.5 7.9 ± 2.4 <0.001 
HbA1c (%) 7.4 (5.9–8.5) 6.0 (5.6–6.8) <0.001 
Known diabetes (%) 76 43 <0.001 
Duration of diabetes (years)* 7 (0–15) 0 (0–4) <0.001 
On insulin or tablets (%) 82 65 0.004 
BMI (kg/m230.3 ± 5.6 30.2 ± 6.1 0.984 
Cholesterol (mmol/l) 5.5 ± 1.0 5.7 ± 1.0 0.115 
Triglycerides (mmol/l) 1.8 (1.3–2.6) 1.9 (1.3–2.7) 0.572 
Current smoker (%) 11 0.574 
Hypertension (%) 72 66 0.288 
SBP (mmHg) 148 ± 24 140 ± 18 <0.001 
DBP (mmHg) 78 ± 10 79 ± 10 0.415 
C-peptide (ng/ml) 3.2 ± 1.7 3.8 ± 1.7 0.001 
Urinary albumin:creatinine ratio (mg/mmol) 1.72 (0.8–6.3) 0.97 (0.6–2.3) <0.001 

Data are mean ± SD or median (interquartile range).

*

Newly diagnosed participants given duration of zero. DBP, diastolic blood pressure.

Close Modal

or Create an Account

Close Modal
Close Modal